Play all audios:
ABSTRACT Here, we report that genome editing by CRISPR–Cas9 induces a p53-mediated DNA damage response and cell cycle arrest in immortalized human retinal pigment epithelial cells, leading
to a selection against cells with a functional p53 pathway. Inhibition of p53 prevents the damage response and increases the rate of homologous recombination from a donor template. These
results suggest that p53 inhibition may improve the efficiency of genome editing of untransformed cells and that p53 function should be monitored when developing cell-based therapies
utilizing CRISPR–Cas9. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution
Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12
print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be
subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR
CONTENT BEING VIEWED BY OTHERS THE APPLICATION AND PROGRESSION OF CRISPR/CAS9 TECHNOLOGY IN OPHTHALMOLOGICAL DISEASES Article 01 August 2022 RESTORATION OF RPGR EXPRESSION IN VIVO USING
CRISPR/CAS9 GENE EDITING Article Open access 14 July 2021 COMPARISON OF CRISPR-CAS13B RNA BASE EDITING APPROACHES FOR USH2A-ASSOCIATED INHERITED RETINAL DEGENERATION Article Open access 08
February 2025 REFERENCES * Hustedt, N. & Durocher, D. _Nat. Cell Biol._ 19, 1–9 (2016). Article PubMed CAS Google Scholar * Hohmann, S. & Gozalbo, D. _Mol. Gen. Genet._ 211,
446–454 (1988). Article PubMed CAS Google Scholar * Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E. _Nat. Biotechnol._ 34, 339–344 (2016). Article PubMed
CAS Google Scholar * DeWitt, M. A. et al. _Sci. Transl. Med._ 8, 360ra134 (2016). Article PubMed PubMed Central CAS Google Scholar * Yin, H. et al. _Nat. Biotechnol._ 32, 551–553
(2014). Article PubMed PubMed Central CAS Google Scholar * Dever, D. P. et al. _Nature_ 539, 384–389 (2016). Article PubMed PubMed Central CAS Google Scholar * Lee, K. et al.
_eLife_ 6, e25312 (2017). * Maruyama, T. et al. _Nat. Biotechnol._ 33, 538–542 (2015). Article PubMed PubMed Central CAS Google Scholar * Schmierer, B. et al. _Mol. Syst. Biol._ 13, 945
(2017). Article PubMed PubMed Central Google Scholar * Luo, M. & Chen, Y. _Int. J. Ophthalmol._ 11, 150–159 (2018). PubMed PubMed Central Google Scholar * Otto, T. &
Sicinski, P. _Nat. Rev. Cancer_ 17, 93–115 (2017). Article PubMed PubMed Central CAS Google Scholar * Sokolova, M. et al. _Cell Cycle_ 16, 189–199 (2017). Article PubMed CAS Google
Scholar * Doench, J. G. et al. _Nat. Biotechnol._ 34, 184–191 (2016). Article PubMed PubMed Central CAS Google Scholar * Wang, J., Vasaikar, S., Shi, Z., Greer, M. & Zhang, B.
_Nucleic Acids Res._ 45, W130–W137 (2017). Article PubMed PubMed Central CAS Google Scholar * Canny, M. D. et al. _Nat. Biotechnol._ 36, 95–102 (2018). Article PubMed CAS Google
Scholar * Cuella-Martin, R. et al. _Mol. Cell_ 64, 51–64 (2016). Article PubMed PubMed Central CAS Google Scholar * Muerdter, F. et al. _Nat. Methods_ 15, 141–149 (2018). Article
PubMed CAS Google Scholar * Li, W. et al. _Genome Biol._ 15, 554 (2014). Article PubMed PubMed Central CAS Google Scholar * Wang, T. et al. _Science_ 350, 1096–1101 (2015). Article
PubMed PubMed Central CAS Google Scholar * Tsai, S. Q. et al. _Nat. Biotechnol._ 33, 187–197 (2015). Article PubMed CAS Google Scholar Download references ACKNOWLEDGEMENTS Part of
this work was carried out at the High Throughput Genome Engineering Facility and the Swedish National Genomics Infrastructure funded by Science for Life Laboratory (Scilifelab). The Knut and
Alice Wallenberg Foundation, Cancerfonden, Barncancerfonden and the Academy of Finland supported this work. We thank H. Han and Y. Bryceson for providing equipment, the Protein Science
Facility at Karolinska Institutet, as well as I. Sur and T. Kivioja for their comments on the manuscript. AUTHOR INFORMATION Author notes * These authors contributed equally: Emma
Haapaniemi, Sandeep Botla. * These authors jointly supervised this work: Bernhard Schmierer, Jussi Taipale. AUTHORS AND AFFILIATIONS * Department of Medical Biochemistry and Biophysics,
Karolinska Institute, Stockholm, Sweden Emma Haapaniemi, Sandeep Botla, Jenna Persson, Bernhard Schmierer & Jussi Taipale * Genome-Scale Biology Program, University of Helsinki,
Helsinki, Finland Emma Haapaniemi & Jussi Taipale * Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom Jussi Taipale Authors * Emma Haapaniemi View author
publications You can also search for this author inPubMed Google Scholar * Sandeep Botla View author publications You can also search for this author inPubMed Google Scholar * Jenna Persson
View author publications You can also search for this author inPubMed Google Scholar * Bernhard Schmierer View author publications You can also search for this author inPubMed Google Scholar
* Jussi Taipale View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS E.H., B.S. and J.T. wrote the manuscript. S.B., B.S. and J.P. conducted
the genome-wide knockout screens. E.H., B.S. and S.B. prepared the cell lines and performed the flow cytometry experiments. J.T. and B.S. supervised the study. All authors read and approved
the final manuscript. CORRESPONDING AUTHORS Correspondence to Bernhard Schmierer or Jussi Taipale. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests.
ADDITIONAL INFORMATION PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION
SUPPLEMENTARY TEXT AND FIGURES Supplementary Figures 1–5 and Supplementary Tables 1–3 REPORTING SUMMARY RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE
Haapaniemi, E., Botla, S., Persson, J. _et al._ CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. _Nat Med_ 24, 927–930 (2018). https://doi.org/10.1038/s41591-018-0049-z
Download citation * Received: 11 September 2017 * Accepted: 23 April 2018 * Published: 11 June 2018 * Issue Date: July 2018 * DOI: https://doi.org/10.1038/s41591-018-0049-z SHARE THIS
ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative